Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

RSR-13 improves median survival in NSCLC

Sep. 26, 2002

Interim phase II results for TOCOSOL(TM) Paclitaxel

Sep. 26, 2002

Selective hypoxic radiosensitizing effects of PR-350 examined in pancreatic cancer cell lines

Sep. 26, 2002

Indolinones disrupt the function of wild-type and mutant Kit

Sep. 26, 2002

ODAC votes for accelerated approval of Iressa

Sep. 26, 2002

Cytokinetics describes preparation and use of mitotic kinesin KSP inhibitors

Sep. 26, 2002

Tarceva receives second fast track designation

Sep. 25, 2002

FDA issues approvable letter for Metvix

Sep. 25, 2002

Worldwide development and marketing agreement for epothilone D in cancer

Sep. 25, 2002

New product for cancer heading for clinical testing at ProMetic

Sep. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...